162 related articles for article (PubMed ID: 29316199)
1. Usefulness of the CLLflow score.
Sorigue M; Franch-Sarto M; Sarrate E; Junca J
Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
[TBL] [Abstract][Full Text] [Related]
2. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD43 in chronic lymphoproliferative leukemias.
Sorigue M; Juncà J; Sarrate E; Grau J
Cytometry B Clin Cytom; 2018 Jan; 94(1):136-142. PubMed ID: 28073173
[TBL] [Abstract][Full Text] [Related]
4. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
5. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
6. FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
Sorigue M; Junca J; Ferra C; Marce S; Ruiz-Xivillé N; Pinyol L; Cabezon M; Espasa A; Dominguez D; Lopez-Viaplana L; Ruiz R; Buch J; Plensa E; Mostacedo SZ; Aranda J; Vergara S; Raya M; Granada I; Tapia G; Navarro JT; Beà S; Zamora L
Cytometry B Clin Cytom; 2020 Sep; 98(5):421-428. PubMed ID: 32530577
[TBL] [Abstract][Full Text] [Related]
7. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
8. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
[TBL] [Abstract][Full Text] [Related]
9. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
[TBL] [Abstract][Full Text] [Related]
10. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
[TBL] [Abstract][Full Text] [Related]
11. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
[TBL] [Abstract][Full Text] [Related]
13. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
[TBL] [Abstract][Full Text] [Related]
14. Refining the Limits of Borderline Lymphoproliferative Disorders.
Sorigue M; Raya M; Vergara S; Sarrate E; Orna E; Juncà J
Cytometry B Clin Cytom; 2019 Sep; 96(5):351-358. PubMed ID: 30592375
[TBL] [Abstract][Full Text] [Related]
15. Consistency of the Moreau CLL score.
Sorigue M; Sarrate E; Franch-Sarto M; Feliu E; Junca J
J Clin Lab Anal; 2018 Jun; 32(5):e22376. PubMed ID: 29282771
[TBL] [Abstract][Full Text] [Related]
16. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
17. The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia.
Ivancević TD; Kurtović NK; Knezević V; Bogdanović A; Mihaljević B; Bozić B; Gotić M
Srp Arh Celok Lek; 2014; 142(3-4):197-203. PubMed ID: 24839775
[TBL] [Abstract][Full Text] [Related]
18. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
19. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
20. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
Sun Y; Wang SA; Sun T
Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]